Coombe, Bender & Co’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $1.24M | Sell |
29,841
-348
| -1% | -$14.5K | 0.73% | 33 |
|
|
2024
Q1 | $1.64M | Buy |
30,189
+3,310
| +12% | +$180K | 0.99% | 27 |
|
|
2023
Q4 | $1.38M | Sell |
26,879
-2,242
| -8% | -$115K | 0.86% | 33 |
|
|
2023
Q3 | $1.69M | Buy |
29,121
+655
| +2% | +$38K | 1.27% | 26 |
|
|
2023
Q2 | $1.82M | Buy |
28,466
+279
| +1% | +$17.8K | 1.33% | 24 |
|
|
2023
Q1 | $1.95M | Buy |
28,187
+1,580
| +6% | +$110K | 1.53% | 24 |
|
|
2022
Q4 | $1.91M | Sell |
26,607
-1,289
| -5% | -$92.7K | 1.75% | 20 |
|
|
2022
Q3 | $1.98M | Sell |
27,896
-67
| -0.2% | -$4.76K | 1.76% | 20 |
|
|
2022
Q2 | $2.15M | Buy |
+27,963
| New | +$2.15M | 1.82% | 16 |
|